郑州大学学报(医学版)
鄭州大學學報(醫學版)
정주대학학보(의학판)
JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES)
2014年
1期
37-40
,共4页
何其栋%魏小玲%张红巧%王威%吴拥军
何其棟%魏小玲%張紅巧%王威%吳擁軍
하기동%위소령%장홍교%왕위%오옹군
决策树%肿瘤标志%肺肿瘤%辅助诊断
決策樹%腫瘤標誌%肺腫瘤%輔助診斷
결책수%종류표지%폐종류%보조진단
decision tree%tumor marker%lung neoplasm%auxiliary diagnosis
目的:应用决策树技术联合肿瘤标志蛋白芯片建立基于“优选肿瘤标志群”的决策树模型,实现对肺癌的快速诊断。方法:运用肿瘤标志定量检测试剂盒测定201例肺部良性疾病及199例肺癌患者血清中9项肿瘤标志[癌胚抗原、糖原类抗原19-9( CA199)、神经元特异性烯醇化酶、CA242、铁蛋白、CA125、甲胎蛋白、人生长激素和CA153]水平,应用logistic回归对肿瘤标志进行筛选以获得“优选肿瘤标志群”,分别于筛选前后建立决策树模型和Fisher判别分析模型。结果:肺癌组9项血清肿瘤标志水平均高于肺良性疾病组(P<0.05)。筛选前基于9项肿瘤标志分别建立的Fisher判别分析模型、决策树模型和筛选后基于6项肿瘤标志建立的Fisher判别分析模型、决策树模型,其预测准确度分别为86.0%、92.5%、84.5%、91.5%。筛选前和筛选后决策树模型ROC曲线的AUC分别为0.925和0.915,均高于Fisher判别分析的0.860和0.845(Z=4.462和4.575,P均<0.01);但决策树模型和Fisher判别分析筛选前后自身相比,差异均无统计学意义(Z=1.914和1.074,P均>0.05)。结论:基于6项肿瘤标志建立的决策树模型诊断肺癌的效果优于Fisher判别分析。
目的:應用決策樹技術聯閤腫瘤標誌蛋白芯片建立基于“優選腫瘤標誌群”的決策樹模型,實現對肺癌的快速診斷。方法:運用腫瘤標誌定量檢測試劑盒測定201例肺部良性疾病及199例肺癌患者血清中9項腫瘤標誌[癌胚抗原、糖原類抗原19-9( CA199)、神經元特異性烯醇化酶、CA242、鐵蛋白、CA125、甲胎蛋白、人生長激素和CA153]水平,應用logistic迴歸對腫瘤標誌進行篩選以穫得“優選腫瘤標誌群”,分彆于篩選前後建立決策樹模型和Fisher判彆分析模型。結果:肺癌組9項血清腫瘤標誌水平均高于肺良性疾病組(P<0.05)。篩選前基于9項腫瘤標誌分彆建立的Fisher判彆分析模型、決策樹模型和篩選後基于6項腫瘤標誌建立的Fisher判彆分析模型、決策樹模型,其預測準確度分彆為86.0%、92.5%、84.5%、91.5%。篩選前和篩選後決策樹模型ROC麯線的AUC分彆為0.925和0.915,均高于Fisher判彆分析的0.860和0.845(Z=4.462和4.575,P均<0.01);但決策樹模型和Fisher判彆分析篩選前後自身相比,差異均無統計學意義(Z=1.914和1.074,P均>0.05)。結論:基于6項腫瘤標誌建立的決策樹模型診斷肺癌的效果優于Fisher判彆分析。
목적:응용결책수기술연합종류표지단백심편건립기우“우선종류표지군”적결책수모형,실현대폐암적쾌속진단。방법:운용종류표지정량검측시제합측정201례폐부량성질병급199례폐암환자혈청중9항종류표지[암배항원、당원류항원19-9( CA199)、신경원특이성희순화매、CA242、철단백、CA125、갑태단백、인생장격소화CA153]수평,응용logistic회귀대종류표지진행사선이획득“우선종류표지군”,분별우사선전후건립결책수모형화Fisher판별분석모형。결과:폐암조9항혈청종류표지수평균고우폐량성질병조(P<0.05)。사선전기우9항종류표지분별건립적Fisher판별분석모형、결책수모형화사선후기우6항종류표지건립적Fisher판별분석모형、결책수모형,기예측준학도분별위86.0%、92.5%、84.5%、91.5%。사선전화사선후결책수모형ROC곡선적AUC분별위0.925화0.915,균고우Fisher판별분석적0.860화0.845(Z=4.462화4.575,P균<0.01);단결책수모형화Fisher판별분석사선전후자신상비,차이균무통계학의의(Z=1.914화1.074,P균>0.05)。결론:기우6항종류표지건립적결책수모형진단폐암적효과우우Fisher판별분석。
Aim:To establish decision tree model based on filtered biomarkers to achieve rapid diagnosis of lung canc -er.Methods:The serum levels of 9 tumor markers (CEA,CA199,NSE,CA242,Ferritin,CA125,AFP,HGH and CA153) in 199 patients with lung cancer and 201 patients with benign pulmonary lesion were measured by multiple tumor marker protein biochip, and the models of C5.0 and Fisher discrimination analysis were developed based on the tumor markers be-fore and after being filtered by logistic regression .Results:The serum levels of the 9 tumor markers in patients with lung cancer were significantly higher than those in patients with benign pulmonary lesion ( P<0 .05 ) .The accuracies of Fisher discrimination analysis and C5.0 models based on 9 tumor markers and 6 tumor markers filtered by logistic regression were 86.0%,92.5%,84.5% and 91.5%, respectively.The area under receiver operating curve (AUC) of C5.0 model was higher than that of Fisher discrimination analysis in both of 9 tumor markers model and 6 tumor markers model(Z=4.462 and 4.575,P<0.01).However, there was no significant difference in AUC between before and after screening in both models(Z=1.914 and 1.074,P>0.05).Conclusion:The effect of the model of C5.0 is better than Fisher discrimina-tion analysis in diagnosis of lung cancer especially based on the tumor markers screened by logistic regression .